163 related articles for article (PubMed ID: 8274404)
1. Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation.
Warriar N; Pagé N; Koutsilieris M; Govindan MV
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):699-711. PubMed ID: 8274404
[TBL] [Abstract][Full Text] [Related]
2. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
Warriar N; Pagé N; Koutsilieris M; Govindan MV
Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Berrevoets CA; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
[TBL] [Abstract][Full Text] [Related]
4. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
5. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT
Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester causes ligand-independent activation of the androgen receptor.
Darne C; Veyssiere G; Jean C
Eur J Biochem; 1998 Sep; 256(3):541-9. PubMed ID: 9780230
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones.
Kemppainen JA; Lane MV; Sar M; Wilson EM
J Biol Chem; 1992 Jan; 267(2):968-74. PubMed ID: 1730684
[TBL] [Abstract][Full Text] [Related]
9. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene.
Hofbauer LC; Hicok KC; Schroeder MJ; Harris SA; Robinson JA; Khosla S
J Cell Biochem; 1997 Sep; 66(4):542-51. PubMed ID: 9282332
[TBL] [Abstract][Full Text] [Related]
12. Atypical androgen receptor in the human melanoma cell line IIB-MEL-J.
Morvillo V; Luthy IA; Bravo AI; Capurro MI; Donaldson M; Quintans C; Calandra RS; Mordoh J
Pigment Cell Res; 1995 Jun; 8(3):135-41. PubMed ID: 7567789
[TBL] [Abstract][Full Text] [Related]
13. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects.
Térouanne B; Tahiri B; Georget V; Belon C; Poujol N; Avances C; Orio F; Balaguer P; Sultan C
Mol Cell Endocrinol; 2000 Feb; 160(1-2):39-49. PubMed ID: 10715537
[TBL] [Abstract][Full Text] [Related]
14. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
Govindan MV
Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
[TBL] [Abstract][Full Text] [Related]
15. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: inhibition of cat expression by anti-androgens.
Fuhrmann U; Bengtson C; Repenthin G; Schillinger E
J Steroid Biochem Mol Biol; 1992 Sep; 42(8):787-93. PubMed ID: 1326316
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens.
Kuil CW; Mulder E
Endocrinology; 1996 May; 137(5):1870-7. PubMed ID: 8612526
[TBL] [Abstract][Full Text] [Related]
17. Modulation of androgen receptor transcriptional activity by the estrogen receptor.
Kumar MV; Leo ME; Tindall DJ
J Androl; 1994; 15(6):534-42. PubMed ID: 7721655
[TBL] [Abstract][Full Text] [Related]
18. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
Fenton MA; Shuster TD; Fertig AM; Taplin ME; Kolvenbag G; Bubley GJ; Balk SP
Clin Cancer Res; 1997 Aug; 3(8):1383-8. PubMed ID: 9815822
[TBL] [Abstract][Full Text] [Related]
20. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
Nguyen TV; Yao M; Pike CJ
Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
